MWMan-Di Wang

Man-Di Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Man-Di Wang has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    AMPK phosphorylation proceeds through hierarchical proteoform cascades revealed by integrated mass spectrometry

    by Boris Krichel, Hsin-Ju Chan, Liam Bandura, Zhan Gao, Man-Di Wang, Holden T. Rogers, Sean J. Mcilwain, Charlotte Uetrecht, Ying Ge

    Protein kinases integrate cellular signals through complex phosphorylation cascades, yet resolving how chemical perturbations trigger and modulate these cascades in therapeutic targets remains a major challenge. Here, we dissect adenosine 5′-monophosphate–activated protein kinase (AMPK) proteoforms during activation through controlled biochemical reactions with a hybrid mass spectrometry (MS) approach integrating bottom-up MS for site-specific kinetics with top-down proteoform characterization. We reveal that AMPK phosphorylation proceeds through hierarchical cascades rather than binary switching, with dual entry points: canonical calcium- and calmodulin-dependent protein kinase kinase 2 (CaMKK2)–mediated phosphorylation or allosteric activator PF-739 both triggering extensive autophosphorylation with α1-Ser496 (S496) showing the highest kinetic priority. Proteoform-resolved analysis uncovers channeled β1-Ser24/25 (S24/25) + Ser108 (S108) cophosphorylation linking subcellular localization with allosteric responsiveness. Site-directed mutagenesis demonstrates CaMKK2 targets only α1-Thr183 (T183), with all other modifications arising through autophosphorylation. Phosphatase competition reveals asymmetric control where PP1A selectively removes activation-loop phosphorylation while autophosphorylation sites remain protected, establishing persistent regulatory states. Resolving AMPK’s temporal kinetics and proteoform architecture during activation enables a proteoform-centric understanding on kinase regulation.


  • Open Access

    Biomimetic Core–Shell Liposome Nanoparticles Deplete Lipoproteins and Enhance the Purity of Extracellular Vesicles from Human Blood

    by Man‐Di Wang, Andrew J. Perciaccante, David Inman, Bong Hwan Sung, Alissa M. Weaver, Suzanne M. Ponik, Ying Ge, Song Jin

    Small extracellular vesicles (sEVs) in human serum carry diverse biomarkers and hold great potential for diagnostic and therapeutic applications. However, their isolation is challenging due to the presence of highly abundant serum proteins, particularly lipoproteins that closely resemble the sEVs in size and density. Existing lipoprotein removal methods cannot effectively remove all types of lipoproteins and may lead to potential contamination. Herein, we developed a lipoprotein‐depleting biomimetic core–shell liposome nanoparticle system composed of Fe 3 O 4 @SiO 2 cores coated with liposome bilayers (SL‐NPs). These lipoprotein‐mimicking nanoparticles exhibit efficient binding to lipoproteins that enable the selective removal of lipoproteins by low‐speed centrifugation while preserving sEVs. When applied as a complementary treatment step, this NP depletion strategy further enhances the purity of sEVs isolated from human serum or human plasma using ultracentrifugation or chemical precipitation methods. Nanoparticle tracking analysis, Western blot, ELISA, and proteomics analysis confirm the depletion of multiple classes of lipoproteins and the improvement of sEV purity after this additional nanoparticle depletion step. This strategy offers a simple, rapid, and effective approach to improve downstream biomarker analysis and applications of blood sEVs.

  • Open Access

    Integrated Multiomics Enabled by Sequential Extraction for Comprehensive Molecular Profiling of Small Extracellular Vesicles

    by Andrew J. Perciaccante, Holden T. Rogers, Yanlong Zhu, Aditi Barnwal, David Inman, Man-Di Wang, Song Jin, Suzanne M. Ponik, Ying Ge

    Small extracellular vesicles (sEVs) are membrane-bound particles whose protein, lipid, and metabolite cargo reflects the molecular state of their cells of origin, making them attractive targets for biomarker discovery and therapeutic development. However, comprehensive characterization of sEVs remains challenging due to the extremely limited material available. Here, we present an integrated mass spectrometry-based multiomics platform for simultaneous characterization of lipids, metabolites, and proteins from a single sEV sample enabled by sequential extraction, maximizing sample utilization. To enhance molecular coverage and analytical depth, the platform combines iterative tandem mass spectrometry for improved small-molecule fragmentation and nanoflow proteomics with data-independent acquisition. We achieved deep and reproducible multiomic characterization of proteins, lipids, and metabolites using 10 million sEVs. We further demonstrated the compatibility of our multiomics platform with sEVs isolated from plasma by ultracentrifugation, size exclusion chromatography with ultrafiltration, and polymer precipitation, revealing purification-dependent differences in molecular profiles associated with trade-offs in yield and purity of sEVs. By enabling integrated multiomics from the same sample, this strategy addresses a key challenge in low-input sEV analysis and establishes a robust analytical foundation for synergistic biomarker discovery and therapeutic applications.

  • Open Access

    CD28‐Targeted Enzyme‐Responsive Conformation‐Switching Peptide Self‐Assembly for Selective T‐Cell Acute Lymphoblastic Leukemia (T‐ALL) Therapy

    by Jun Li, Ziyu Jia, Dekun Li, Zhi‐Wen Hu, Yinghao Ding, Shengyi Zhang, Shengkun Tuo, Zhimou Yang, Huisheng Fu, Ling Wang, et al.

    T‐cell acute lymphoblastic leukemia (T‐ALL) is a highly aggressive hematologic malignancy with limited targeted therapies. CD28, a costimulatory receptor aberrantly overexpressed on T‐ALL cells, presents a promising underexplored therapeutic target. In this study, we developed an enzyme‐responsive self‐assembling peptide, SA p ‐CD28, designed to target CD28 and undergo receptor‐mediated self‐assembly in the tumor microenvironment. Upon dephosphorylation by overexpressed phosphatases, SA p ‐CD28 transitions from an α‐helix to a β‐sheet/β‐turn rich structure, facilitating the formation of nanooligomers that engage CD28 and activate cytotoxic pathways. Transcriptomic and biochemical analyses reveal that SA p ‐CD28 induces a profound dysregulation of CD28 downstream signaling, characterized by the suppression of the PLCγ and Akt pathways. These signaling perturbations lead to oxidative stress and disruption of intracellular calcium homeostasis, resulting in calcium overload, calpain activation, and cytoskeletal collapse. Besides, confocal imaging suggested that the peptide self‐assembly can enter the nucleus and disrupt it. In Jurkat xenograft models, SA p ‐CD28 demonstrated potent antitumor activity, and its combination with cytarabine resulted in near‐complete tumor suppression, highlighting its potential for T‐ALL treatment. This work introduces a CD28‐targeted, enzyme‐activated nanotherapeutic strategy that synergizes biochemical and mechanical mechanisms to selectively eliminate T‐ALL cells. This multi‐mechanistic tumor‐killing strategy can also be extended to inspire therapeutic approaches for other diseases.


  • Open Access

    Integrated Multi-Omics Enabled by Sequential Extraction for Comprehensive Molecular Profiling of Small Extracellular Vesicles

    by Andrew J. Perciaccante, Holden Tyler Rogers, Yanlong Zhu, Aditi Barnwal, David Inman, Man-Di Wang, Song Jin, Suzanne M. Ponik, Ying Ge

    Small extracellular vesicles (sEVs) are membrane-bound particles whose protein, lipid, and metabolite cargo reflects the molecular state of their cells of origin, making them attractive targets for biomarker discovery and therapeutic development. However, comprehensive characterization of sEVs remains challenging due to the extremely limited material available. Here, we present an integrated mass spectrometry-based multi-omics platform for simultaneous characterization of lipids, metabolites, and proteins from a single sEV sample enabled by sequential extraction, maximizing sample utilization. To enhance molecular coverage and analytical depth, the platform combines iterative tandem mass spectrometry for improved small-molecule fragmentation and nano-flow proteomics with data-independent acquisition. We achieved deep and reproducible multi-omic characterization of proteins, lipids, and metabolites using 10 million sEVs. We further demonstrated the compatibility of our multi-omics platform with sEVs isolated from plasma by ultracentrifugation, size-exclusion chromatography with ultrafiltration, and polymer precipitation, revealing purification-dependent differences in molecular profiles associated with tradeoffs in yield and purity of sEVs. By enabling integrated multi-omics from the same sample, this strategy addresses a key challenge in low-input sEV analysis and establishes a robust analytical foundation for synergistic biomarker discovery and therapeutic applications.

  • Open Access

    AMPK Phosphorylation Proceeds Through Hierarchical Proteoform Cascades Revealed by Integrated Mass Spectrometry

    by Boris Krichel, Hsin-Ju Chan, Liam Bandura, Zhan Gao, Man-Di Wang, Holden T. Rogers, Sean J. Mcilwain, Charlotte Uetrecht, Ying Ge

    Protein kinases integrate cellular signals through complex phosphorylation cascades, yet resolving how chemical perturbations trigger and modulate these cascades in therapeutic targets remains a major challenge. Here, we dissect AMP-activated protein kinase (AMPK) proteoforms during activation through controlled biochemical reactions with a hybrid mass spectrometry (MS) approach integrating bottom-up MS for site-specific kinetics with top-down proteoform characterization. We reveal that AMPK phosphorylation proceeds through hierarchical cascades rather than binary switching, with dual entry points: canonical CaMKK2-mediated phosphorylation or allosteric activator PF-739 both triggering extensive autophosphorylation with α1-S496 showing highest kinetic priority. Proteoform-resolved analysis uncovers channeled β1-S24/25+S108 co-phosphorylation linking subcellular localization with allosteric responsiveness. Site-directed mutagenesis demonstrates CaMKK2 targets only α1-T183, with all other modifications arising through autophosphorylation. Phosphatase competition reveals asymmetric control where PP1A selectively removes activation-loop phosphorylation while autophosphorylation sites remain protected, establishing persistent regulatory states. Resolving AMPK’s temporal kinetics and proteoform architecture during activation enables a proteoform-centric understanding on kinase regulation.


  • Open Access

    Structural Heterogeneity of Proteoform-Ligand Complexes in Adenosine Monophosphate-Activated Protein Kinase Uncovered by Integrated Top-Down Mass Spectrometry

    by Hsin-Ju Chan, Boris Krichel, Liam J. Bandura, Emily A. Chapman, Holden T. Rogers, Matthew S. Fischer, David S. Roberts, Zhan Gao, Man-Di Wang, Jingshing Wu, et al.

    Adenosine monophosphate-activated protein kinase (AMPK) is a heterotrimeric complex (αβγ) that serves as a master regulator of cellular metabolism, making it a prominent drug target for various diseases. Post-translational modifications (PTMs) and ligand binding significantly affect the activity and function of AMPK. However, the dynamic interplay of PTMs, noncovalent interactions, and higher-order structures of the kinase complex remains poorly understood. Herein, we report for the first time the structural heterogeneity of the AMPK complex arising from ligand binding and proteoforms─protein products derived from PTMs, alternative splicing, and genetic variants─using integrated native and denatured top-down mass spectrometry (TDMS). The fully intact AMPK heterotrimeric complex exhibits heterogeneity due to phosphorylation and multiple adenosine monophosphate (AMP) binding states. Native TDMS delineates the subunit composition, AMP binding stoichiometry, and higher-order structure of AMPK complex, while denatured TDMS comprehensively characterizes the proteoforms and localizes the phosphorylation site. Notably, by integrating native TDMS and AlphaFold, we elucidate a flexibly connected regulatory region of AMPK β subunit that was previously unresolvable with traditional structural biology tools. Our findings offer new perspectives on protein kinase regulation and establish a versatile framework for comprehensive characterization of proteoform-ligand complexes.


  • Open Access

    Structural Heterogeneity of Proteoform-Ligand Complexes in AMP-Activated Protein Kinase Uncovered by Integrated Top-Down Mass Spectrometry

    by Hsin-Ju Chan, Boris Krichel, Liam J. Bandura, Emily A. Chapman, Holden T. Rogers, Matthew S. Fischer, David S. Roberts, Zhan Gao, Man-Di Wang, Jingshing Wu, et al.

    AMP-activated protein kinase (AMPK) is a heterotrimeric complex (αβγ) that serves as a master regulator of cellular metabolism, making it a prominent drug target for various diseases. Post-translational modifications (PTMs) and ligand binding significantly affect the activity and function of AMPK. However, the dynamic interplay of PTMs, non-covalent interactions, and higher-order structures of the kinase complex remains poorly understood. Herein, we report the structural heterogeneity of the AMPK complex arising from ligand binding and proteoforms—protein products derived from PTMs, alternative splicing, and genetic variants—using integrated native and denatured top-down mass spectrometry (TDMS). The fully intact AMPK heterotrimeric complex exhibits heterogeneity due to phosphorylation and multiple adenosine monophosphate (AMP) binding states. Native TDMS delineates the subunit composition, AMP binding stoichiometry, and higher-order structure of AMPK complex, whilst denatured TDMS comprehensively characterizes the proteoforms and localizes the phosphorylation site. This is the first study to structurally characterize AMPK proteoform-ligand complexes. Notably, by integrating native TDMS and AlphaFold, we elucidate a flexibly connected regulatory region of AMPK β subunit that has been difficult to visualize with traditional structural biology tools. Our findings uncover previously unresolvable structural features of AMPK, offer new perspectives on protein kinase regulation, and establish a versatile framework for comprehensive characterization of proteoform-ligand complexes.

  • Homologous Peptide Foldamer Promotes FUS Aggregation and Triggers Cancer Cell Death

    by Man-Di Wang, Li Yi, Yanying Li, Ruiwen Xu, Jiaojiao Hu, Da-Yong Hou, Cong Liu, Hao Wang

    Fused in sarcoma (FUS), a multifunctional deoxyribonucleic acid (DNA)/ribonucleic acid (RNA)-binding protein, has been implicated in various cancer types, including sarcoma and leukemia. Despite its association with these diseases, there has been limited exploration of FUS as a cancer therapy target, primarily because its dynamic nature makes it difficult to target specifically. In this study, we explored a kind of β-sheet peptide foldamer, named β4-TAT, to influence FUS aggregation by targeting its RNA recognition motifs (RRM). This approach leverages the noncovalent interaction characteristics of peptide self-assembly processes. The β4 sequence, derived from the FUS RRM β-sheet, in combination with TAT, a peptide known for its nuclear targeting capability, enables β4-TAT to bind specifically to the analogous β4 sequence within FUS. Notably, β4-TAT effectively induces FUS aggregation within cells, leading to the death of cancer cells. Our work developed a novel peptide foldamer-based strategy for inducing protein aggregation, paving the way for innovative therapeutic approaches in targeting FUS-associated cancers.


  • Open Access

    Structure and dynamics of endogenous protein complexes in human heart tissue captured by native nanoproteomics

    by Emily A. Chapman, David S. Roberts, Timothy N. Tiambeng, Jãán Andrews, Man-Di Wang, Emily A. Reasoner, Jake A. Melby, Brad H. Li, Donguk Kim, Andrew J. Alpert, et al.

    Protein complexes are highly dynamic entities that display substantial diversity in their assembly, post-translational modifications, and non-covalent interactions, allowing them to play critical roles in various biological processes. The heterogeneity, dynamic nature, and low abundance of protein complexes in their native states present tremendous challenges to study using conventional structural biology techniques. Here we develop a “native nanoproteomics” strategy for the native enrichment and subsequent native top-down mass spectrometry (nTDMS) of of low-abundance protein complexes. Specifically, we demonstrate the first comprehensive characterization of the structure and dynamics of cardiac troponin (cTn) complexes directly from human heart tissue. The endogenous cTn complex is effectively enriched and purified using peptide-functionalized superparamagnetic nanoparticles under non-denaturing conditions to enable the isotopic resolution of cTn complexes, revealing their complex structure and assembly. Moreover, nTDMS elucidates the stoichiometry and composition of the heterotrimeric cTn complex, localizes Ca 2+ binding domains (II-IV), defines cTn-Ca 2+ binding dynamics, and provides high-resolution mapping of the proteoform landscape. This native nanoproteomics strategy opens a new paradigm for structural characterization of low-abundance native protein complexes.